Abstract:Objective To investigate the clinical characteristics of elderly patients with congestive heart failure (CHF) complicated with hyperuricemia (HUA) and to analyze the value of uric acid-lowering therapy in improving the prognosis of HUA patients. Methods A total of 316 elderly CHF patients admitted to the Second Affiliated Hospital of Xi′an Jiaotong University from July 2020 to May 2023 were enrolled as the study subjects. According to the serum uric acid (SUA) levels at admission, they were divided into HUA group and non-HVA (NHUA) group. The clinical data were compared between two groups, and the clinical characteristics of elderly CHF patients with HUA were analyzed. The in-hospital mortality was recorded. The factors affecting the in-hospital mortality in elderly CHF patients were analyzed by the Cox proportional hazards regression model. The patients in the HUA group were randomized into HUA-trial group and HUA-control group. The trial group received uric acid-lowering allopurinol in addition to routine medication. After one year of follow-up, the intervention effects were compared. SPSS 27.0 was used for statistical analysis. Data comparison between two groups was performed using t test or χ2test depending on data type. Results Among the 316 CHF patients, 180 (56.96%) were diagnosed with HUA . The HUA group had higher levels of SUA, plasma N-terminal pro-brain natriuretic peptide (NT-proBNP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), white blood cell count (WBC), and proportion of patients with New York Heart Association (NYHA) functional class Ⅲ-Ⅳ than the NHUC group, but lower left ventricular ejection fraction (LVEF), with statistically significant differences (P<0.05). Among 316 elderly CHF patients, 23 (7.28%) died in hospital. Multivariate Cox proportional hazards regression analysis indicated that age ≥ 80 years (HR=1.399, 95%CI 1.093-1.791), NT-proBNT level (HR=1.067, 95%CI 1.022-1.114), and diuretic dose within 24 h of admission (HR=1.123, 95%CI 1.040-1.212) were risk factor for in-hospital death, and systolic blood pressure (SBP) at admission (HR=0.911, 95%CI 0.846-0.982) was a protective factor (P<0.05). After one year of follow-up, levels of serum creatinine, SUA, NT-proBNP, IL-6, TNF-α, WBC, and left ventricular end-diastolic diameter in the HUA-trial group were lower than those in the HUA-control group, while the LVEF was higher than that in the HUA-control group, with statistically significant differences (P<0.05). The incidence of composite endpoint events after one year of follow-up was 39.02% (32/82) in the HUA-experimental group, lower than 59.76% (49/82) in the HUA-control group (χ2=7.050; P=0.008). Conclusion The SUA level at admission is not associated with in-hospital mortality in elderly CHF patients, but uric acid-lowering therapy can reduce the incidence of composite endpoint events one year after discharge.